Surgical sponge detection company ClearCount Medical Solutions has raised $1.5 million, according to a regulatory filing.
Pittsburgh-based ClearCount has been quiet on the fundraising front since August 2010, when it announced a $5 million series B round of investment led by Draper Triangle Ventures.
ClearCount Medical has developed the SmartSponge and SmartWand systems, which use radio-frequency identification (RFID) technology and chips embedded in sponges to allow surgeons and nurses to detect and count sponges during operations.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
ClearCount’s latest funding comes in the form of options and debt and was sourced from one investor, according to the regulatory filing.
Surgical sponges are the most frequent and dangerous “retained surgical items” (RSIs) that are mistakenly left inside patients.
ClearCount says its products can reduce or eliminate preventable hospital costs and delays associated with RSIs, including additional surgery and infection costs, litigation and unnecessary X-rays.
Earlier this year, ClearCount released a new product, the SmartSponge Flex, which features improved design for OR use, according to the company.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
ClearCount has at least two major competitors that take different approaches to surgical sponge detection: SurgiCount Medical uses bar-coding technology and RF Surgical Systems uses electronic surveillance technology.
ClearCount CEO David Palmer didn’t immediately return a call.
